Early Sepsis-Associated Acute Kidney Injury and Obesity

被引:5
|
作者
Ahn, Yoon Hae [1 ]
Yoon, Si Mong [2 ]
Lee, Jinwoo [2 ]
Lee, Sang-Min [1 ,2 ]
Oh, Dong Kyu [3 ]
Lee, Su Yeon [3 ]
Park, Mi Hyeon [3 ]
Lim, Chae-Man [3 ]
Lee, Hong Yeul [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Crit Care Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea
[3] Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea
关键词
CRITICALLY-ILL PATIENTS; CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; INTENSIVE-CARE; REVERSE EPIDEMIOLOGY; URINE OUTPUT; MORTALITY; IMPACT; MECHANISMS; GUIDELINES;
D O I
10.1001/jamanetworkopen.2023.54923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance The prevalence of obesity is increasing in the intensive care unit (ICU). Although obesity is a known risk factor for chronic kidney disease, its association with early sepsis-associated acute kidney injury (SA-AKI) and their combined association with patient outcomes warrant further investigation. Objective To explore the association between obesity, early SA-AKI incidence, and clinical outcomes in patients with sepsis. Design, Setting, and Participants This nationwide, prospective cohort study analyzed patients aged 19 years or older who had sepsis and were admitted to 20 tertiary hospital ICUs in Korea between September 1, 2019, and December 31, 2021. Patients with preexisting stage 3A to 5 chronic kidney disease and those with missing body mass index (BMI) values were excluded. Exposures Sepsis and hospitalization in the ICU. Main Outcomes and Measures The primary outcome was SA-AKI incidence within 48 hours of ICU admission, and secondary outcomes were mortality and clinical recovery (survival to discharge within 30 days). Patients were categorized by BMI (calculated as weight in kilograms divided by height in meters squared), and data were analyzed by logistic regression adjusted for key characteristics and clinical factors. Multivariable fractional polynomial regression models and restricted cubic spline models were used to analyze the clinical outcomes with BMI as a continuous variable. Results Of the 4041 patients (median age, 73 years [IQR, 63-81 years]; 2349 [58.1%] male) included in the study, 1367 (33.8%) developed early SA-AKI. Obesity was associated with a higher incidence of SA-AKI compared with normal weight (adjusted odds ratio [AOR], 1.40; 95% CI, 1.15-1.70), as was every increase in BMI of 10 (OR, 1.75; 95% CI, 1.47-2.08). While obesity was associated with lower in-hospital mortality in patients without SA-AKI compared with their counterparts without obesity (ie, underweight, normal weight, overweight) (AOR, 0.72; 95% CI, 0.54-0.94), no difference in mortality was observed in those with SA-AKI (AOR, 0.85; 95% CI, 0.65-1.12). Although patients with obesity without SA-AKI had a greater likelihood of clinical recovery than their counterparts without obesity, clinical recovery was less likely among those with both obesity and SA-AKI. Conclusions and Relevance In this cohort study of patients with sepsis, obesity was associated with a higher risk of early SA-AKI and the presence of SA-AKI modified the association of obesity with clinical outcomes.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Sepsis-associated acute kidney injury: is COVID-19 different?
    Kellum, John A.
    Nadim, Mitra K.
    Forni, Lui G.
    KIDNEY INTERNATIONAL, 2020, 98 (06) : 1370 - 1372
  • [32] Metabolism as Disease Tolerance: Implications for Sepsis-Associated Acute Kidney Injury
    Huen, Sarah C.
    NEPHRON, 2022, 146 (03) : 291 - 294
  • [33] Choline supplementation attenuates experimental sepsis-associated acute kidney injury
    Hasson, Denise C.
    Watanabe-Chailland, Miki
    Romick-Rosendale, Lindsey
    Koterba, Adeleine
    Miner, Dashiell S.
    Lahni, Patrick
    Ma, Qing
    Goldstein, Stuart L.
    Devarajan, Prasad
    Standage, Stephen W.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2022, 323 (03) : F255 - F271
  • [34] The application of omic technologies to research in sepsis-associated acute kidney injury
    Denise Hasson
    Stuart L. Goldstein
    Stephen W. Standage
    Pediatric Nephrology, 2021, 36 : 1075 - 1086
  • [35] Recent advances in the pharmacological management of sepsis-associated acute kidney injury
    Kalantari, Kambiz
    Rosner, Mitchell H.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (11) : 1401 - 1411
  • [36] The role of phospholipid transfer protein in sepsis-associated acute kidney injury
    Jiang, Wei
    Song, Lin
    Gong, Weilei
    Li, Xianghui
    Shi, Keran
    Li, Luanluan
    Zhang, Chuanqing
    Wang, Jing
    Xu, Xiaolan
    Wang, Haixia
    Wu, Xiaoyan
    Shao, Jun
    Yu, Yang
    Yu, Jiangquan
    Zheng, Ruiqiang
    CRITICAL CARE, 2025, 29 (01)
  • [37] The application of omic technologies to research in sepsis-associated acute kidney injury
    Hasson, Denise
    Goldstein, Stuart L.
    Standage, Stephen W.
    PEDIATRIC NEPHROLOGY, 2021, 36 (05) : 1075 - 1086
  • [38] The Potential of Alkaline Phosphatase as a Treatment for Sepsis-Associated Acute Kidney Injury
    Peters, Esther
    Masereeuw, Rosalinde
    Pickkers, Peter
    NEPHRON CLINICAL PRACTICE, 2014, 127 (1-4): : 144 - 148
  • [39] Sepsis-associated Acute Kidney Injury, Diagnosis, and Management, Review Article
    Alghamdi, Abdullah Mohammed
    Alghamdi, Assem Mohammed
    Alsemairi, Saif Awadh B.
    Alangari, Abdulaziz Abdullah
    Alabbad, Mahmoud Abdullah
    Alebrahim, Ebaa Ali
    Albluwi, Rawan Ahmad
    Almaymn, Abdulrahman Ibrahim
    Alawfi, Abdulrhman Mahbob
    Alkhanjaf, Hayder Saleh
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (03): : 129 - 136
  • [40] Not All Sepsis-Associated Acute Kidney Injury Is the Same There May Be an App for That
    Gunning, Samantha
    Koyner, Jay L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (11): : 1543 - 1545